Press & News
The next generation biopharmaceuticals
Press releases 2013
2013-11-19
Older press releases
2013-09-17
New molecular imaging agents being developed for fluorescence-guided brain cancer surgery
Affibodys latest Press releases
2022-05-03
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report January to March 2020 (May 15, 2020)
- Interim Report January to June 2020 (August 21, 2020)
- Interim Report January to September 2020 (November 13, 2020)
- Year End Report 2020 (February 2021)